Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management - Scorecard - MDSpire

Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management

  • By

  • Christina Abi Faraj

  • Ian E. McCutcheon

  • June 6, 2026

  • 0 min

Share

Clinical Scorecard: Post-Stereotactic Radiosurgery Pituitary Hormone Dysfunction in Patients with Pituitary Adenomas: Understanding Mechanisms and Treatment Approaches

At a Glance

CategoryDetail
Condition
Key MechanismsHormonal dysfunction due to damage from tumor or treatment (SRS) - needs source.
Target Population
Care Setting

Key Highlights

  • SRS is used for tumor control and hormonal normalization in PAs - needs source.

Guideline-Based Recommendations

Diagnosis

    Management

    • Surgical resection is preferred for symptomatic NFPAs and FPAs - needs source.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Remove unsupported claim about SRS effectiveness.

        Clinical Best Practices

        • Consider surgical debulking prior to SRS for better outcomes - needs source.

        Related Resources & Content

        Original Source(s)

        Related Content